Toleranzia AB logo

Toleranzia AB jobs and careers

Sweden

As of October 24, 2026, Toleranzia AB has no open roles listed.

About Toleranzia AB

Toleranzia develops protein-based antigen-specific immune tolerogens to cure patients with autoimmune diseases. The drugs have the potential to become the first long-acting or curative therapies that act specifically on the underlying cause of the autoimmune orphan disease for which they are being developed. The company has a lead project in myasthenia gravis as well as a second project in ANCA vasculitis. Toleranzia is listed on the Nasdaq First North Growth Market and backed by strongly committed renowned specialist investors.

Founded
2011
Employees
1 to 10
Total funding
$71K
Headquarters
Sweden

Leadership

The top of Toleranzia AB's org chart, with how many people report into each leader.

BL

Bjorn Lowenadler

Chief Business Officer

Jobs at Toleranzia AB

No open positions right now. Explore more companies on TheJobsMap.

Toleranzia AB jobs: common questions

Is Toleranzia AB hiring right now?
Toleranzia AB has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Toleranzia AB's careers site.
Where is Toleranzia AB headquartered?
Toleranzia AB is headquartered in Sweden and was founded in 2011.
Who leads Toleranzia AB?
Bjorn Lowenadler, Chief Business Officer, is at the top of Toleranzia AB's org chart.
How do I apply for a job at Toleranzia AB?
Pick a role on Toleranzia AB's TheJobsMap page and select Apply. Every listing links to the original posting on Toleranzia AB's own careers site, so you apply directly with the employer.